Pulsenmore Ltd's Comment on Sales, Marketing and Customers
The company operates in the mobile diagnostic imaging market, focusing on home-use ultrasound devices linked to telehealth and prenatal care. Its primary product, the Pulsenmore ES, is a home-use prenatal ultrasound device within the obstetrics and gynecology ultrasound segment, which includes cart-based, portable, and handheld devices for imaging the female reproductive system and monitoring fetal development. The company differentiates its device from other prenatal and fertility products such as non-invasive prenatal testing, maternal serum screening kits, wearable fetal monitors, ovulation test strips, and fertility monitors by targeting ongoing prenatal monitoring from home through patient self-scanning. The global prenatal, fetal, and neonatal equipment market was valued at approximately $4.2 billion in 2024 and is projected to reach $7.1 billion by 2033. The global market for portable ultrasound devices, including those compatible with mobile phones like the Pulsenmore ES and Pulsenmore FC, was valued at approximately $5.7 billion in 2024 and is expected to grow due to patient preference for home-based diagnostics, concerns about clinic visits, healthcare costs, and capacity constraints in healthcare facilities.
Pulsenmore Ltd’s Comment on Sales, Marketing and Customers
The company operates in the mobile diagnostic imaging market, focusing on home-use ultrasound devices linked to telehealth and prenatal care. Its primary product, the Pulsenmore ES, is a home-use prenatal ultrasound device within the obstetrics and gynecology ultrasound segment, which includes cart-based, portable, and handheld devices for imaging the female reproductive system and monitoring fetal development. The company differentiates its device from other prenatal and fertility products such as non-invasive prenatal testing, maternal serum screening kits, wearable fetal monitors, ovulation test strips, and fertility monitors by targeting ongoing prenatal monitoring from home through patient self-scanning. The global prenatal, fetal, and neonatal equipment market was valued at approximately $4.2 billion in 2024 and is projected to reach $7.1 billion by 2033. The global market for portable ultrasound devices, including those compatible with mobile phones like the Pulsenmore ES and Pulsenmore FC, was valued at approximately $5.7 billion in 2024 and is expected to grow due to patient preference for home-based diagnostics, concerns about clinic visits, healthcare costs, and capacity constraints in healthcare facilities.
Sources:
Pulsenmore Ltd’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Pulsenmore Ltd’s corporate clients.
For your research, we’ve provided 9 tables on Pulsenmore Ltd corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
